Guam § 67 - Cooperative Arrangements and Confidentiality.

§ 67. Cooperative Arrangements and Confidentiality.

(a) The Attorney General, DPHSS and GPD shall cooperate with Federal and other state agencies in

discharging their responsibilities concerning traffic in controlled substances and in suppressing the abuse

of controlled substances. To this end, the Attorney General, DPHSS and GPD may:

(1) arrange for the exchange of information among governmental officials concerning the use and

abuse of controlled substances;

(2) coordinate and cooperate in training programs concerning controlled substance law

enforcement at local and state levels;

(3) cooperate with the Drug Enforcement Administration by establishing a centralized unit to

accept, catalog, file and collect statistics, including records of drug dependent persons and other

controlled substance law offenders within Guam, and make the information available for Federal, state

and local law enforcement purposes, but may not furnish the name or identity of a patient or research

subject whose identity could not be obtained under Subsection (c); and

(4) conduct programs of eradication aimed at destroying wild growth or unlawful propagation of

plant species from which controlled substances may be extracted.

(b) Results, information and evidence received from the DEA relating to the regulatory functions of

this Act, including results of inspections conducted by it, may be relied and acted upon by DPHSS and

GPD in the exercise of its regulatory functions under this Act.

(c) A practitioner engaged in medical practice or research is not required or compelled to furnish the

name or identity of a patient or research subject to DPHSS, nor may the practitioner be compelled in any

COL 2024-12-05

state or local civil, criminal, administrative, legislative or other proceedings to furnish the name or identity

of an individual that the practitioner is obligated to keep confidential; provided however, that nothing herein

shall be construed to prevent DPHSS from conducting a triplicate prescription program or any other drug

monitoring program pursuant to rules adopted by DPHSS.